Sergio Barreto
- Private Equity
NovaQuest backs German pharma’s osteoarthritis treatment
NovaQuest Capital Management expanded is royalty pipeline with a deal to support development of German pharmaceutical firm Grünenthal’s lead asset,…
Read More » - Private Equity
SoCal VC firm Morpheus closes second disruptive tech fund at $200m
Morpheus Ventures closed its second discretionary capital fund oversubscribed fund above its target of $200 million in commitments. Fund II…
Read More » - Manager News
HarbourView acquires Latin superstar’s music catalog
It took HarbourView Equity Partners about three months to start putting to use the $1 billion fund it launched with…
Read More » - Private Equity
EQT acquires majority interest in Asia cancer center network
Barely a week after expanding its footprint in the European healthcare venture capital sector via an agreement to acquire Life…
Read More » - Manager News
EQT expands European life sciences VC opportunities with LSP acquisition
Swedish private equity giant EQT() is expanding its footprint in the European healthcare venture capital sector after entering into an…
Read More » - Manager News
Blackstone bets up to $250 million on UK biotech’s leukemia treatment
Blackstone Life Sciences tossed a lifeline to UK biotechnology firm Autolus Therapeutics in a deal structured to unlock revenues for…
Read More » - Manager News
Blackstone validates music rights as alts assets with $1bn partnership
If there were any doubts left about the value of music rights as an alternative investment asset class, the $1…
Read More » - Private Equity
European life sciences player HealthCap announces new hire, promotions
European life sciences venture capital firm HealthCap appointed Dr. Mårten Steen as co-managing partner, taking a seat alongside Founding Partner…
Read More » - Private Equity
UBS kicks MPM Capital oncology impact fund into record territory
MPM Capital expected to raise $650 million for its second Oncology Impact Fund (OIF 2), which would have been more…
Read More » - Manager News
Blackstone’s BioMed Realty makes big lab space play in Cambridge, UK
Blackstone portfolio company BioMed Realty is investing an estimated £850 million ($1.16 billion) to purchase two properties in Cambridge, UK,…
Read More »